Evidence map›Paper›PMID 36051396›Full record

ArticleFrontiers in endocrinology2022

Dental health of pediatric patients with X-linked hypophosphatemia (XLH) after three years of burosumab therapy.

Rafi Brener, Leonid Zeitlin, Yael Lebenthal, Avivit Brener

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 27 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. The Diagnosis and Therapy of XLH.Calcified tissue international · 2025
    Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Rafi BrenerThe Endodontic Unit, Galilee College of Dental Sciences, Galilee Medical Center, Nahariya, Israel.
Leonid ZeitlinThe Metabolic Bone Disease Unit, Dana-Dwek Children's Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Yael LebenthalSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Avivit BrenerSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Tel Aviv University · ILBar-Ilan University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An inactivating

Indexed as

Familial Hypophosphatemic RicketsAbscessAdolescentAntibodies, Monoclonal, HumanizedCase-Control StudiesChildChild, PreschoolFibroblast Growth FactorsHumansAntibodies, Monoclonal, HumanizedburosumabFibroblast Growth Factorsdental abscessdental morphologyFGF23ricketsX-linked hypophosphatemia

Identifiers

PMID36051396
PMCPMC9425915
OpenAlexW4291378066

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.